Your browser doesn't support javascript.
loading
Use of elexacaftor/tezacaftor/ivacaftor in liver transplant patients with cystic fibrosis.
McKinzie, Cameron J; Doligalski, Christina T; Lobritto, Steven J; Coakley, Raymond D; Gower, W Adam.
Afiliação
  • McKinzie CJ; Department of Pharmacy, University of North Carolina Medical Center, Chapel Hill, NC, United States. Electronic address: Cameron.mckinzie@unchealth.unc.edu.
  • Doligalski CT; Department of Pharmacy, University of North Carolina Medical Center, Chapel Hill, NC, United States.
  • Lobritto SJ; Center for Liver Disease and Transplantation, Columbia University, New York, NY, United States.
  • Coakley RD; Marsico Lung Institute, University of North Carolina at Chapel Hill, Chapel Hill, NC, United States.
  • Gower WA; Division of Pediatric Pulmonology, Department of Pediatrics, University of North Carolina School of Medicine, Chapel Hill, NC, United States.
J Cyst Fibros ; 21(2): 227-229, 2022 03.
Article em En | MEDLINE | ID: mdl-34384711
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Transplante de Fígado / Fibrose Cística Tipo de estudo: Diagnostic_studies Limite: Humans Idioma: En Revista: J Cyst Fibros Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Transplante de Fígado / Fibrose Cística Tipo de estudo: Diagnostic_studies Limite: Humans Idioma: En Revista: J Cyst Fibros Ano de publicação: 2022 Tipo de documento: Article